|
| ||
|
|
||
Catheter Design (catheter + design)
Selected AbstractsThe Ablation of Atrial Fibrillation with the Loop Catheter Design: What We Have Learned From the Animal ModelPACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 7 2001BOAZ AVITALL AVITALL, B., et al.: The Ablation of Atrial Fibrillation with the Loop Catheter Design: What We Have Learned From the Animal Model. Ablation of chronic atrial fibrillation (AF) with the use of transcutaneous catheter ablation is yet to become a clinical tool. This article summarizes the development of the technology and the technique for the ablation of AF that was tested on the rapidly paced AF dog model. The current ablation technology using the standard ablation technique used in humans is not suitable for the creation of transmural contiguous linear lesions, and such technology is subjecting the patient to the prolonged procedures with considerable risk of complication. The use of the loop catheter design or other designs of ablation technology, which is specifically targeted for the creation of linear lesions, should be developed if the catheter approach for the ablation of AF is to succeed. This article describes the data available for the loop catheter design that is currently undergoing human feasibility studies. [source] The mechanisms of coronary restenosis: insights from experimental modelsINTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Issue 2 2000Gordon A.A. Ferns Since its introduction into clinical practice, more than 20 years ago, percutaneous transluminal coronary angioplasty (PTCA) has proven to be an effective, minimally invasive alternative to coronary artery bypass grafting (CABG). During this time there have been great improvements in the design of balloon catheters, operative procedures and adjuvant drug therapy, and this has resulted in low rates of primary failure and short-term complications. However, the potential benefits of angioplasty are diminished by the high rate of recurrent disease. Up to 40% of patients undergoing angioplasty develop clinically significant restenosis within a year of the procedure. Although the deployment of endovascular stents at the time of angioplasty improves the short-term outcome, ,in-stent' stenosis remains an enduring problem. In order to gain an insight into the mechanisms of restenosis, several experimental models of angioplasty have been developed. These have been used together with the tools provided by recent advances in molecular biology and catheter design to investigate restenosis in detail. It is now possible to deliver highly specific molecular antagonists, such as antisense gene sequences, to the site of injury. The knowledge provided by these studies may ultimately lead to novel forms of intervention. The present review is a synopsis of our current understanding of the pathological mechanisms of restenosis. [source] The Ablation of Atrial Fibrillation with the Loop Catheter Design: What We Have Learned From the Animal ModelPACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 7 2001BOAZ AVITALL AVITALL, B., et al.: The Ablation of Atrial Fibrillation with the Loop Catheter Design: What We Have Learned From the Animal Model. Ablation of chronic atrial fibrillation (AF) with the use of transcutaneous catheter ablation is yet to become a clinical tool. This article summarizes the development of the technology and the technique for the ablation of AF that was tested on the rapidly paced AF dog model. The current ablation technology using the standard ablation technique used in humans is not suitable for the creation of transmural contiguous linear lesions, and such technology is subjecting the patient to the prolonged procedures with considerable risk of complication. The use of the loop catheter design or other designs of ablation technology, which is specifically targeted for the creation of linear lesions, should be developed if the catheter approach for the ablation of AF is to succeed. This article describes the data available for the loop catheter design that is currently undergoing human feasibility studies. [source] | ||||||||||